Creating R&D Incentives for Medicines for Neglected Diseases: An Economic Analysis of Parallel Imports, Patents, and Alternative Mechanisms to Stimula by Frank Müller-LangerCreating R&D Incentives for Medicines for Neglected Diseases: An Economic Analysis of Parallel Imports, Patents, and Alternative Mechanisms to Stimula by Frank Müller-Langer

Creating R&D Incentives for Medicines for Neglected Diseases: An Economic Analysis of Parallel…

byFrank Müller-Langer

Paperback | July 28, 2009

Pricing and Purchase Info

$148.02 online 
$167.95 list price save 11%
Earn 740 plum® points

Prices and offers may vary in store

Quantity:

In stock online

Ships free on orders over $25

Not available in stores

about

This book is the revised version of a doctoral thesis written at the Graduiertenkolleg Law and Economics at Hamburg University. It addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of access to affordable medicines in poor countries. Tropical diseases, such as malaria or leishmaniasis, are among the main causes of death and disability in developing countries. Medical scholars have since long argued that medicines for those neglected infectious diseases either do not exist at all or badly need improvement. This neglect has two main reasons. First, tropical diseases virtually do not occur in the rich countries of the Northern Hemisphere where the bulk of new pharmaceutical inventions are made. Second, intellectual property protection in poor countries of the Southern Hemisphere, i. e. patents or copyrights, is often poorly developed. The innovator faces the risk of losing research and development (R&D) costs as imitators can offer generic drugs at marginal costs. Therefore, not much research is targeted at developing medicines for tropical diseases as the expected market returns from R&D in the private pharmaceuticals sector are too low. Frank Müller-Langer provides a well-researched outline of the legal landscape regarding international patent protection. He focuses on the relevant provisions stated in the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement), which is aimed at harmonizing and strengthening intellectual property protection around the world.
Dr. Frank Müller-Langer is a research fellow at the Max Planck Institute for Intellectual Property, Competition and Tax Law and academic coordinator of the International Max Research School for Competition and Innovation in Munich. He obtained his doctorate in economics from Hamburg University in 2008.
Loading
Title:Creating R&D Incentives for Medicines for Neglected Diseases: An Economic Analysis of Parallel…Format:PaperbackDimensions:316 pagesPublished:July 28, 2009Publisher:Gabler VerlagLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3834917303

ISBN - 13:9783834917300

Look for similar items by category:

Reviews

Table of Contents

The TRIPS Agreement and Access to Patented Medicines; Economic Analysis of Patents ; Patent Protection in the Developing World; Legal und Economic Analysis of Parallel Imports; Solutions for the Problem of Underinvestment in R&D for Medicines for Neglected Infectious and Tropical Diseases